In the latest sign of anger over the cost of insulin, the Minnesota attorney general on Tuesday filed a lawsuit accusing the three largest manufacturers — Eli Lilly, Sanofi (SNY) and Novo Nordisk (NVO) — with deceptively raising prices, the first state to go to court over the issue.

“Insulin is a life-or-death drug for people with diabetes,” said Minnesota Attorney General Lori Swanson in a statement. “Many people can’t afford the price hikes but can’t afford to stop taking the medication either.” As an example, the lawsuit cited the Lantus insulin sold by Sanofi, which cost $99.35 for a 10-milliliter vial in 2010, now costs $269.54.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • When I was on Medicare and a supplement insurance, I was paying $1000 a month for my insulin. Now, working for HealthPartners, I have excellent insurance and only pay $10 for a month’s worth of insulin. At $1000, I told my endocrinologist that it was either the mortgage or the insulin….I could not afford both.

Your daily dose of news in health and medicine

Privacy Policy